Sanofi India Limited — Dividend/Bonus, 27-02-2025: Dividend

Sanofi India Limited has announced a board meeting on February 27, 2025, where it approved the final dividend of ₹117 per equity share for the fiscal year ending December 31, 2024, pending shareholder approval at the upcoming Annual General Meeting. For Q4-2024, Sanofi reported a 21% increase in standalone profit from operations, reaching ₹108 Cr, driven by strong performance in its diabetes portfolio and partnerships in CNS and cardiovascular brands. The company's total income was ₹5,208 Cr, while the profit for the year stood at ₹3,137 Cr, reflecting robust operational growth post-demerger of its consumer healthcare business.